Composition: Methylcobalamin, Alpha Lipoic Acid, Folic Acid & Pyridoxine Hydrochloride Capsules

Dosage Form: Capsules

Packaging Type: ALU ALU

Packaging: 10*10

View Pdf




Description

VTV FORMULATIONS INDIA PVT LTD is here to offer the best range of products for your problems. Our company manufactures and supplies top-notch quality products that people most trust. VTV FORMULATIONS INDIA PVT LTD  manufactures Cefixime Tablets IP (200 mg), therefore serve our customers with quality life and healthcare products. All the products made by us are GMP, WHO, and ISO-certified.

Use of best raw materials for manufacturing 

Adherence to quality control and quality assurance practices.

Certified companies from ISO, GMP, and WHO.

Air-tight and leak-proof packaging.

Cefixime-200 Tablet is used to treat susceptible organisms (bacteria)-caused infections of the ear, nose, sinuses (sinusitis), throat (tonsillitis, pharyngitis), chest and lungs (bronchitis, pneumonia) and urinary system (cystitis and kidney infections). Additionally, it is also prescribed to treat uncomplicated gonorrhoea (cervical/urethral).Cefixime-200 Tablet contains Cefixime, which works by inhibiting cell wall synthesis. In turn, Cefixime-200 Tablet weakens and destroys the bacterial cell wall, leading to death. As a result, Cefixime-200 Tablet helps to treat bacterial infections.

Take Cefixime-200 Tablet as directed by the physician. Sometimes, you may experience common side effects such as diarrhoea, nausea, loose stools, abdominal pain, dyspepsia, indigestion, and vomiting. Most of these side effects do not require medical attention and resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.

Side Effects

  • Diarrhoea

  • Nausea

  • Loose stools

  • Abdominal pain

  • Dyspepsia or indigestion

  • Vomiting

Over Services

Subscribe

Stay ahead in healthcare with our curated pharmaceutical products Subscribe now for exclusive access to the latest innovations.

Copyright @2021.All rights reserved.